
1/ 🧵Thrilled to share that our new paper was just published at @ScienceTM @aaas ! 🎉 We show how the complement system boosts the ability of antibodies to neutralize SARS-CoV-2, especially recent variants. 🦠🧫 science.org/doi/10.1126/scit… A thread ⬇️

Group Leader Antiviral Activities of Antibodies @Virus_Immunity @institutpasteur - Virology/Immunology - Member @SFV_France - @timotheebruel.bsky.social

1/ 🧵Thrilled to share that our new paper was just published at @ScienceTM @aaas ! 🎉 We show how the complement system boosts the ability of antibodies to neutralize SARS-CoV-2, especially recent variants. 🦠🧫 science.org/doi/10.1126/scit… A thread ⬇️

We’re joining X with something important to share. Two studies published in @ScienceMagazine last Thursday shed new light on a virus that made headlines this year, and show why international scientific collaboration matters. A thread 🧵

Cross-reactive antibody and functional T-cell responses to Bundibugyo virus induced by Zaire ebolavirus vaccination and infection medrxiv.org/content/10.64898… #Ebola #vaccine #outbreak

Type I IFN autoantibodies in three of seven Europeans with life-threatening Usutu virus infection rupress.org/jhi/article/3/1/…

Less than two weeks left to apply for a PhD in the lab! Details and application 👇 👇 👇
🧑🔬PhD Opportunity! Together with @Mahan_Ghafari (Oxford uni) we're advertising an exciting project on exploring the deep evolutionary and structural conservation of viral antigen proteins, through Pasteur's prestigious PPU program! Apply here: ppu.pasteur.fr

Introducing Sentira Single Cell, a new agentic analysis platform. Explore Chromium data with natural language, refine analyses in editable, reproducible notebooks and stay in control from scientific questions to experimental conclusions: bit.ly/47PCu18

I’m recruiting a Postdoctoral Fellow to join my lab at the Harvard T.H. Chan School of Public Health, working on innate immunity to RNA viruses. To apply, please email a CV and a letter of interest to jlpinfo@hsphsun3.harvard.edu. Details: academicpositions.harvard.ed…

🚀 Excited to share BindClaw! 🦀 Starting from a prompt or research paper, BindClaw connects biological mechanisms to protein design: identify targets and binding sites → build mechanism-specific computational assays → generate and assess binders → refine designs using the results. We use agents to evaluate whether designs fit the intended biological objective, including competition with a native partner and preference for a particular molecular state. 🧬 In a human-guided calmodulin campaign, 15 of 18 designs showed binding to calcium-loaded CaM, including subnanomolar binders supported by both BLI and SPR. This work is an incredible team effort together with @DidiKieran , @saint__ai, @ Kyle Gion and @sacdallago and many others! 📄paper/project: research.nvidia.com/labs/dbr… 💻code: will be released in a few weeks!

🎃 All treats, no tricks. Run RFD4-Proteina on RTX PRO 6000 GPUs on @huggingface, free until Nov 4. You can design proteins in your browser without installing anything. huggingface.co/spaces/nvidia…

Paper alert from our lab in collaboration with Nadine Laguette and Dorothée MISSÉ’s labs. Have you ever heard if Tonate virus? :) The RLR-MAVS-IRF3 axis activates the IFN pathway to restrict Tonate virus infection journals.plos.org/plosntds/a…

« For clinical trials, I'd even call human-only review dangerous » I felt like that AI reviews are reliable and objective as compared to human ones. Amazing to seer this quantified. Given the burden of reviewing it raises many interesting question…
Lots of debate this week on whether journals should ban AI in peer review. We actually tested this in our new preprint, and the results were pretty clear to me. For context, I've reviewed for most of the big journals and evaluated 1,000 human reviews as an editor. I love to read and evaluate science. TLDR: From now on I won't do any peer review without AI. For clinical trials, I'd even call human-only review dangerous 🧵

Our BA.3.2.2 study is now published in Nature Microbiology! Counterintuitively, we found that ancestral-strain immune imprinting protects against BA.3.2.2 through IGHV3-53/66 Class 1 antibodies, helping explain why BA.3.2.2 selectively infects children. doi.org/10.1038/s41564-026-0…

Nature research paper: Structural basis for protocadherin-1 recognition by New World hantaviruses go.nature.com/4ieepFS

What an amazing opportunity !
Today, we’re announcing an open call for guest investigators in life sciences. Over 8–12 weeks, guest investigators will work directly with my team and other Anthropic researchers to produce analyses and tools for their work. We’ll run our models and harnesses, at no cost to them. We’ll work together to open-source the resulting data, artifacts, and code, and write preprints about what we find. We want humans to remain at the center of scientific discovery, deciding what questions to pursue, and how to pursue them. Those decisions are not ours to make alone. This open call is part of our ongoing efforts at Anthropic to support researchers and accelerate scientific discovery. I’m looking for principal investigators and their research groups at academic institutions, nonprofits, or government labs, working in causal human biology, structural and computational molecular biology, medicinal chemistry, drug discovery, and clinical science. Applications are open for about 14 days: anthropic.com/news/open-call…

Need compute to compete in protein design competitions like this one? proteinbase.com/competitions… RFD4-Proteina is now on Hugging Face with two weeks of NVIDIA-sponsored access. 🧵👇

China has selected its first group of young researchers to receive funding for up to 15 years, in one of the longest research grants on offer to scientists globally go.nature.com/4z4Q3pw